Evrofarma SA logo

EVROF - Evrofarma SA Share Price

€0.77 0.0  0.8%

Last Trade - 11:17am

Sector
Consumer Defensives
Size
Micro Cap
Market Cap £9.54m
Enterprise Value £25.6m
Revenue £30.6m
Position in Universe 614th / 720
Bullish
Bearish
Unlock EVROF Revenue
Momentum
Relative Strength (%)
1m -4.07%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -44.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
25.3 29.6 28.9 30.6 32.5 33.5 +5.8%
-52.4 +36.7 +104.6 -10.7
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2019, EvroFarma S.A. revenues increased 3% to EUR33.5M. Net income decreased 84% to EUR157K. Revenues reflect Sale of Biological items increase from EUR1M to EUR3.4M. Net income was offset by Distribution - Balancing value increase of 7% to EUR3.8M (expense), Interest Expense - Short Term Loans increase from EUR52K to EUR133K (expense), Depreciation in Selling increase of 17% to EUR118K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

EVROF Revenue Unlock EVROF Revenue

Net Income

EVROF Net Income Unlock EVROF Revenue

Normalised EPS

EVROF Normalised EPS Unlock EVROF Revenue

PE Ratio Range

EVROF PE Ratio Range Unlock EVROF Revenue

Dividend Yield Range

EVROF Dividend Yield Range Unlock EVROF Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
EVROF EPS Forecasts Unlock EVROF Revenue
Profile Summary

Evrofarma SA is a Greece-based company engaged in the production and trade of dairy products. The Company offers five ranges of products: Milk, including fresh whole, semi-skimmed and skimmed milk, highly pasteurized milk and chocolate flavored milk; the traditional Ariani Milk Drink, available also with added flavors; Yogurt, including traditional, cow-milk and strained yogurt; Milk Cream, as well as Cheese, such as goat, feta and organic feta cheese and anthotiro. It also supplies the yellow cheeses of Doiranis brand, including traditional kasseri and semi-hard cheeses. The Company’s milk supplies come from various farmers and associates in Macedonia and Thrace. Its production facilities cover 10,000 square meters and it has four distribution centers in Northern Greece, as well as a fleet of privately owned trucks that distribute its products in more than 3,000 points of sale locations. Evrofarma SA has a wholly owned subsidiary, Campus SA, which deals mainly with milk production.

Directors
Last Annual December 31st, 2019
Last Interim December 31st, 2019
Incorporated July 17, 1991
Public Since June 12, 2000
No. of Shareholders: n/a
No. of Employees: 99
Sector Consumer Defensives
Industry Food & Tobacco
Index
Exchange Athens Exchange
Shares in Issue 13,673,200
Free Float (0.0%)
Eligible for
ISAs
SIPPs
EVROF Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for EVROF
Upcoming Events for EVROF
Frequently Asked Questions for Evrofarma SA
What is the Evrofarma SA share price?

As of 11:17am, shares in Evrofarma SA are trading at €0.77, giving the company a market capitalisation of £9.54m. This share price information is delayed by 15 minutes.

How has the Evrofarma SA share price performed this year?

Shares in Evrofarma SA are currently trading at €0.77 and the price has moved by -22.2% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Evrofarma SA price has moved by -17.18% over the past year.

What are the analyst and broker recommendations for Evrofarma SA?

There are no analysts currently covering Evrofarma SA.

When will Evrofarma SA next release its financial results?

Evrofarma SA is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-12-31
What is the Evrofarma SA dividend yield?

Evrofarma SA does not currently pay a dividend.

Does Evrofarma SA pay a dividend?

Evrofarma SA does not currently pay a dividend.

When does Evrofarma SA next pay dividends?

Evrofarma SA does not currently pay a dividend.

How do I buy Evrofarma SA shares?

To buy shares in Evrofarma SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Evrofarma SA?

Shares in Evrofarma SA are currently trading at €0.77, giving the company a market capitalisation of £9.54m.

Where are Evrofarma SA shares listed? Where are Evrofarma SA shares listed?

Here are the trading details for Evrofarma SA:

Country of listing: Greece
Exchange: ATH
Ticker Symbol: EVROF
What kind of share is Evrofarma SA?

Based on an overall assessment of its quality, value and momentum, Evrofarma SA is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Evrofarma SA share price forecast 2020?

We were not able to load any forecast data for Evrofarma SA.

How can I tell whether the Evrofarma SA share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Evrofarma SA. Over the past six months, the relative strength of its shares against the market has been -27.11%. At the current price of €0.77, shares in Evrofarma SA are trading at -20.57% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Evrofarma SA PE Ratio?

The Evrofarma SA PE ratio based on its reported earnings over the past 12 months is 12.77. The shares are currently trading at €0.77.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Evrofarma SA?

Evrofarma SA's management team is headed by:

Athanasios Papazilakis - CHM
Paschalis Papazilakis - VCH
Anastasios Alexandridis - NED
Dimitrios Giannoulakis - EDR
Panagiotis Theodoridis - NED
Nikolaos Mpozmpouazis - CFO
Who are the major shareholders of Evrofarma SA?

Here are the top five shareholders of Evrofarma SA based on the size of their shareholding:

Papazilakis (Paschalis) Individual Investor
Percentage owned: 38.71% (5.29m shares)
Papazilakis (Athanasios) Individual Investor
Percentage owned: 37.31% (5.10m shares)
Similar to EVROF
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.